Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Migraine
Related studies linked through entity extraction aliases.
Dexamethasone for Migraine - Dose Comparison
- Status
- COMPLETED
- Phase
- PHASE4
Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
- Status
- TERMINATED
- Phase
- NA
Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy
- Status
- COMPLETED
- Phase
- N/A
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
- Status
- COMPLETED
- Phase
- PHASE4
Heartmath Migraine Study
- Status
- COMPLETED
- Phase
- NA
Vibratory Stimulation for the Treatment of Chronic Pain
- Status
- SUSPENDED
- Phase
- NA
Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE4
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
- Status
- SUSPENDED
- Phase
- N/A
Neurophysiology of Prophylactic Treatment in Migraine
- Status
- COMPLETED
- Phase
- N/A
A Study Investigating the Efficacy of GON Blocks.
- Status
- COMPLETED
- Phase
- PHASE4
Diary-based Study on the Course of Hormone-withdrawal Migraines
- Status
- COMPLETED
- Phase
- N/A
Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients
- Status
- COMPLETED
- Phase
- NA
Outcomes of Migraine Surgery
- Status
- WITHDRAWN
- Phase
- N/A
Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
- Status
- RECRUITING
- Phase
- PHASE3
Trigeminal Brainstem Mapping
- Status
- COMPLETED
- Phase
- NA
A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
- Status
- COMPLETED
- Phase
- PHASE1
Telehealth Behavioral Migraine Management
- Status
- COMPLETED
- Phase
- NA